Exhibit 12 - Berenbaum Subcutaneous Tanezumab for OA Efficacy and Safety Results Ann Rheum Dis 2020 79 800-810
NonrulemakingSupporting & Related MaterialFDA-2026-P-6249-0020
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 3, 2026
- Agency
- Food and Drug Administration (FDA)